Monday, December 7, 2009

Emidoxin




Emidoxin may be available in the countries listed below.


Ingredient matches for Emidoxin



Cefonicid

Cefonicid disodium salt (a derivative of Cefonicid) is reported as an ingredient of Emidoxin in the following countries:


  • Italy

International Drug Name Search

Friday, December 4, 2009

Indapamid Actavis




Indapamid-Actavis may be available in the countries listed below.


Ingredient matches for Indapamid-Actavis



Indapamide

Indapamide is reported as an ingredient of Indapamid-Actavis in the following countries:


  • Austria

Indapamide hemihydrate (a derivative of Indapamide) is reported as an ingredient of Indapamid-Actavis in the following countries:


  • Germany

International Drug Name Search

Saturday, November 21, 2009

Finix




Finix may be available in the countries listed below.


Ingredient matches for Finix



Rabeprazole

Rabeprazole is reported as an ingredient of Finix in the following countries:


  • Bangladesh

International Drug Name Search

Saturday, October 31, 2009

Mentolo Farmacologico




Mentolo Farmacologico may be available in the countries listed below.


Ingredient matches for Mentolo Farmacologico



Levomenthol

Levomenthol is reported as an ingredient of Mentolo Farmacologico in the following countries:


  • Italy

International Drug Name Search

Wednesday, October 21, 2009

Thrombocytopenia Autoimmune Medications


There are currently no drugs listed for "Thrombocytopenia Autoimmune". See Thrombocytopenia.





Drug List:

Farvicett




Farvicett may be available in the countries listed below.


Ingredient matches for Farvicett



Cetrimide

Cetrimide is reported as an ingredient of Farvicett in the following countries:


  • Italy

Chlorhexidine

Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Farvicett in the following countries:


  • Italy

International Drug Name Search

Friday, October 16, 2009

Insulin Penmix 10




Insulin Penmix 10 may be available in the countries listed below.


Ingredient matches for Insulin Penmix 10



Insulin Injection, Biphasic Isophane

Insulin Injection, Biphasic Isophane human (a derivative of Insulin Injection, Biphasic Isophane) is reported as an ingredient of Insulin Penmix 10 in the following countries:


  • Greece

International Drug Name Search

Thursday, October 15, 2009

Sinergia




Sinergia may be available in the countries listed below.


Ingredient matches for Sinergia



Amoxicillin

Amoxicillin is reported as an ingredient of Sinergia in the following countries:


  • Ecuador

Clavulanate

Clavulanic Acid is reported as an ingredient of Sinergia in the following countries:


  • Ecuador

International Drug Name Search

Atenolol Genericon comp.




Atenolol Genericon comp. may be available in the countries listed below.


Ingredient matches for Atenolol Genericon comp.



Atenolol

Atenolol is reported as an ingredient of Atenolol Genericon comp. in the following countries:


  • Austria

Chlortalidone

Chlortalidone is reported as an ingredient of Atenolol Genericon comp. in the following countries:


  • Austria

International Drug Name Search

Monday, October 12, 2009

Roxflan




Roxflan may be available in the countries listed below.


Ingredient matches for Roxflan



Amlodipine

Amlodipine besilate (a derivative of Amlodipine) is reported as an ingredient of Roxflan in the following countries:


  • Brazil

International Drug Name Search

Thursday, October 1, 2009

Disodium Folinate




Disodium Folinate may be available in the countries listed below.


Ingredient matches for Disodium Folinate



Folinic Acid

Disodium Folinate (BAN) is also known as Folinic Acid (BAN)

International Drug Name Search

Glossary

BANBritish Approved Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Saturday, September 19, 2009

Lubrilac




Lubrilac may be available in the countries listed below.


Ingredient matches for Lubrilac



Hypromellose

Hypromellose is reported as an ingredient of Lubrilac in the following countries:


  • Greece

International Drug Name Search

Tuesday, September 15, 2009

Udocaine




Udocaine may be available in the countries listed below.


Ingredient matches for Udocaine



Lidocaine

Lidocaine is reported as an ingredient of Udocaine in the following countries:


  • Thailand

International Drug Name Search

Artem




Artem may be available in the countries listed below.


Ingredient matches for Artem



Artemether

Artemether is reported as an ingredient of Artem in the following countries:


  • Myanmar

International Drug Name Search

Sunday, September 13, 2009

EC Doparl




EC Doparl may be available in the countries listed below.


Ingredient matches for EC Doparl



Benserazide

Benserazide hydrochloride (a derivative of Benserazide) is reported as an ingredient of EC Doparl in the following countries:


  • Japan

Levodopa

Levodopa is reported as an ingredient of EC Doparl in the following countries:


  • Japan

International Drug Name Search

Friday, September 11, 2009

Momentum




In the US, Momentum is a member of the drug class analgesic combinations.

Ingredient matches for Momentum



Paracetamol

Paracetamol is reported as an ingredient of Momentum in the following countries:


  • Austria

Salicylic Acid

Salicylic Acid magnesium (a derivative of Salicylic Acid) is reported as an ingredient of Momentum in the following countries:


  • United States

International Drug Name Search

Tuesday, September 1, 2009

Valdefer




Valdefer may be available in the countries listed below.


Ingredient matches for Valdefer



Ferrous Sulfate

Ferrous Sulfate is reported as an ingredient of Valdefer in the following countries:


  • Mexico

International Drug Name Search

Monday, August 31, 2009

Nimodipin Carino




Nimodipin Carino may be available in the countries listed below.


Ingredient matches for Nimodipin Carino



Nimodipine

Nimodipine is reported as an ingredient of Nimodipin Carino in the following countries:


  • Germany

International Drug Name Search

Wednesday, August 19, 2009

Sucralfato ABC




Sucralfato ABC may be available in the countries listed below.


Ingredient matches for Sucralfato ABC



Sucralfate

Sucralfate is reported as an ingredient of Sucralfato ABC in the following countries:


  • Italy

International Drug Name Search

Sunday, August 16, 2009

Risperidon-1A Pharma




Risperidon-1A Pharma may be available in the countries listed below.


Ingredient matches for Risperidon-1A Pharma



Risperidone

Risperidone is reported as an ingredient of Risperidon-1A Pharma in the following countries:


  • Austria

  • Germany

International Drug Name Search

Sunday, August 9, 2009

Fevarin




Fevarin may be available in the countries listed below.


Ingredient matches for Fevarin



Fluvoxamine

Fluvoxamine maleate (a derivative of Fluvoxamine) is reported as an ingredient of Fevarin in the following countries:


  • Bulgaria

  • Croatia (Hrvatska)

  • Czech Republic

  • Denmark

  • Estonia

  • Finland

  • Georgia

  • Germany

  • Hungary

  • Italy

  • Latvia

  • Lithuania

  • Netherlands

  • Norway

  • Poland

  • Romania

  • Russian Federation

  • Slovakia

  • Sweden

International Drug Name Search

Wednesday, August 5, 2009

Neofarmiz




Neofarmiz may be available in the countries listed below.


Ingredient matches for Neofarmiz



Azithromycin

Azithromycin dihydrate (a derivative of Azithromycin) is reported as an ingredient of Neofarmiz in the following countries:


  • Portugal

International Drug Name Search

Monday, August 3, 2009

Erythromycin Genericon




Erythromycin Genericon may be available in the countries listed below.


Ingredient matches for Erythromycin Genericon



Erythromycin

Erythromycin ethylsuccinate (a derivative of Erythromycin) is reported as an ingredient of Erythromycin Genericon in the following countries:


  • Austria

International Drug Name Search

Friday, July 10, 2009

Flexin




Flexin may be available in the countries listed below.


Ingredient matches for Flexin



Cyclobenzaprine

Cyclobenzaprine hydrochloride (a derivative of Cyclobenzaprine) is reported as an ingredient of Flexin in the following countries:


  • Chile

Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Flexin in the following countries:


  • Argentina

Orphenadrine

Orphenadrine citrate (a derivative of Orphenadrine) is reported as an ingredient of Flexin in the following countries:


  • Israel

International Drug Name Search

Dynastat




Dynastat may be available in the countries listed below.


UK matches:

  • Dynastat 20mg & 40mg Powder for Solution for Injection, Dynastat 20mg & 40mg Powder & Solvent for Solution for Injection (SPC)

Ingredient matches for Dynastat



Parecoxib

Parecoxib is reported as an ingredient of Dynastat in the following countries:


  • Ireland

  • Slovakia

Parecoxib sodium salt (a derivative of Parecoxib) is reported as an ingredient of Dynastat in the following countries:


  • Australia

  • Austria

  • Bahrain

  • Belgium

  • Czech Republic

  • Denmark

  • Finland

  • France

  • Germany

  • Greece

  • Hong Kong

  • Hungary

  • Iceland

  • Indonesia

  • Italy

  • Luxembourg

  • Mexico

  • Myanmar

  • Netherlands

  • New Zealand

  • Norway

  • Peru

  • Philippines

  • Portugal

  • Romania

  • Russian Federation

  • Slovenia

  • Spain

  • Sweden

  • Thailand

  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday, July 8, 2009

Diprosalic




Diprosalic may be available in the countries listed below.


UK matches:

  • Diprosalic Ointment (SPC)
  • Diprosalic Scalp Application (SPC)

Ingredient matches for Diprosalic



Aspirin

Acetylsalicylic Acid is reported as an ingredient of Diprosalic in the following countries:


  • Finland

  • Italy

Betamethasone

Betamethasone is reported as an ingredient of Diprosalic in the following countries:


  • Croatia (Hrvatska)

  • Netherlands

  • Poland

  • Slovenia

Betamethasone 17α,21-dipropionate (a derivative of Betamethasone) is reported as an ingredient of Diprosalic in the following countries:


  • Austria

  • Bahrain

  • Belgium

  • Canada

  • Croatia (Hrvatska)

  • Czech Republic

  • Denmark

  • Finland

  • France

  • Georgia

  • Germany

  • Iceland

  • Indonesia

  • Italy

  • Luxembourg

  • Norway

  • Oman

  • Peru

  • Slovakia

  • South Africa

  • Spain

  • Sweden

  • Switzerland

  • United Kingdom

Salicylic Acid

Salicylic Acid is reported as an ingredient of Diprosalic in the following countries:


  • Belgium

  • Canada

  • Croatia (Hrvatska)

  • Denmark

  • France

  • Germany

  • Indonesia

  • Netherlands

  • Oman

  • Poland

  • Slovenia

  • South Africa

  • Spain

  • Sweden

  • Switzerland

  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Tuesday, July 7, 2009

Clorilex




Clorilex may be available in the countries listed below.


Ingredient matches for Clorilex



Clozapine

Clozapine is reported as an ingredient of Clorilex in the following countries:


  • Indonesia

International Drug Name Search

Loristal




Loristal may be available in the countries listed below.


Ingredient matches for Loristal



Loratadine

Loratadine is reported as an ingredient of Loristal in the following countries:


  • Peru

International Drug Name Search

Saturday, July 4, 2009

Vesselon




Vesselon may be available in the countries listed below.


Ingredient matches for Vesselon



Cyclandelate

Cyclandelate is reported as an ingredient of Vesselon in the following countries:


  • Taiwan

International Drug Name Search

Saturday, June 20, 2009

Tricefin




Tricefin may be available in the countries listed below.


Ingredient matches for Tricefin



Ceftriaxone

Ceftriaxone disodium salt (a derivative of Ceftriaxone) is reported as an ingredient of Tricefin in the following countries:


  • Indonesia

  • Singapore

International Drug Name Search

Saturday, June 13, 2009

Parillex




Parillex may be available in the countries listed below.


Ingredient matches for Parillex



Tiemonium Methylsulfate

Tiemonium Methylsulfate is reported as an ingredient of Parillex in the following countries:


  • Bangladesh

International Drug Name Search

Tuesday, June 9, 2009

Ketotifen Help




Ketotifen Help may be available in the countries listed below.


Ingredient matches for Ketotifen Help



Ketotifen

Ketotifen is reported as an ingredient of Ketotifen Help in the following countries:


  • Greece

International Drug Name Search

Monday, June 8, 2009

Arox




Arox may be available in the countries listed below.


Ingredient matches for Arox



Enoxacin

Enoxacin is reported as an ingredient of Arox in the following countries:


  • Bahrain

  • Egypt

  • Iraq

  • Jordan

  • Kuwait

  • Lebanon

  • Libya

  • Qatar

  • Saudi Arabia

  • Sudan

  • Syria

  • United Arab Emirates

  • Yemen

International Drug Name Search

Friday, June 5, 2009

Requip



Generic Name: ropinirole (Oral route)

roe-PIN-i-role

Commonly used brand name(s)

In the U.S.


  • Requip

  • Requip XL

Available Dosage Forms:


  • Tablet

  • Tablet, Extended Release

Therapeutic Class: Antiparkinsonian


Pharmacologic Class: Dopamine Agonist


Uses For Requip


Ropinirole is used alone or with other medicines to treat Parkinson's disease.


It is also used to treat a condition called Restless Legs Syndrome (RLS). RLS is a neurologic disorder that affects sensation and movement in the legs and causes the legs to feel uncomfortable. This results in an overwhelming feeling of wanting to move your legs to make them comfortable.


This medicine is available only with your doctor's prescription.


Before Using Requip


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies have not been performed on the relationship of age to the effects of ropinirole in the pediatric population. Safety and efficacy have not been established.


Geriatric


Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of ropinirole in the elderly. However, elderly patients are more likely to have age-related liver problems or to develop hallucinations (seeing, hearing, or feeling things that are not there), which may require caution in patients receiving ropinirole.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersCAnimal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Warfarin

Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Ciprofloxacin

  • Kava

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using this medicine with any of the following may cause an increased risk of certain side effects but may be unavoidable in some cases. If used together, your doctor may change the dose or how often you use this medicine, or give you special instructions about the use of food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Dyskinesia (trouble controlling your muscles) or

  • Hallucinations or

  • Heart or heart rhythm problems or

  • Hypertension (high blood pressure) or

  • Hypotension (low blood pressure) or

  • Mental illness or

  • Postural hypotension (dizziness, lightheadedness, or fainting when getting up from a lying or sitting position)—Ropinirole may make these conditions worse.

  • Kidney problems—May increase chance of side effects.

  • Liver problems—Higher blood levels of ropinirole may result, and cause an increase in side effects.

  • Lung problems resulting from treatment with some other Parkinson's disease medicines—Ropinirole may cause the condition to recur.

  • Sleep disorders or

  • Sleepiness, history of in the past—May cause side effects to be worse.

Proper Use of ropinirole

This section provides information on the proper use of a number of products that contain ropinirole. It may not be specific to Requip. Please read with care.


Take this medicine every day exactly as ordered by your doctor in order to improve your condition as much as possible. Do not take more of it or less of it, and do not take it more or less often than your doctor ordered.


Read the Patient Information leaflet before you take this medicine and each time you get your prescription refilled.


This medicine may be taken with or without food, or on an empty or full stomach. Taking this medicine with food may reduce nausea.


Swallow the extended-release tablets whole. Do not split, crush, or chew it.


Dosing


The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For oral dosage form (extended-release tablets):
    • For Parkinson's disease:
      • Adults—At first, 2 milligrams (mg) once a day for 1 to 2 weeks. Your doctor may increase your dose as needed and tolerated. However, the dose is usually not more than 24 mg per day.

      • Children—Use and dose must be determined by your doctor.



  • For oral dosage form (tablets):
    • For Parkinson's disease:
      • Adults—At first, 0.25 milligrams (mg) three times a day. Your doctor will increase your dose as needed and tolerated. However, the dose is usually not more than 24 mg a day.

      • Children—Use and dose must be determined by your doctor.


    • For Restless Legs Syndrome:
      • Adults—At first, 0.25 mg once a day, 1 to 3 hours before bedtime. Your doctor will increase your dose as needed and tolerated. However, the dose is usually not more than 4 mg a day.

      • Children—Use and dose must be determined by your doctor.



Missed Dose


If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.


Storage


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Ask your healthcare professional how you should dispose of any medicine you do not use.


Precautions While Using Requip


It is important that your doctor check your progress at regular visits to allow changes in your dose and to check for any unwanted effects.


Do not stop taking this medicine without first checking with your doctor. Your doctor may want you to reduce gradually the amount you are taking before stopping completely.


People taking ropinirole have reported falling asleep without warning during activities of daily living, including driving, which sometimes resulted in accidents. This may happen as late as one year after taking the medicine. Therefore, make sure you know how you react to this medicine before you drive, use machines, or do anything else that could be dangerous if you are not alert, well-coordinated, or able to think or see well.


This medicine will add to the effects of alcohol and other CNS depressants (medicines that slow down the nervous system, possibly causing drowsiness). Some examples of CNS depressants are antihistamines or medicine for hay fever, other allergies, or colds; sedatives, tranquilizers, or sleeping medicine; prescription pain medicine or narcotics; barbiturates; medicine for seizures; muscle relaxants; or anesthetics, including some dental anesthetics. Check with your doctor before taking any of the above while you are using this medicine.


Dizziness, lightheadedness, or fainting may occur, especially when you get up from a lying or sitting position. These symptoms are more likely to occur when you begin taking this medicine, or when the dose is increased. Getting up slowly may help. If you should have this problem, check with your doctor.


Hallucinations may occur in some patients. This is more common with elderly patients. If you have hallucinations, check with your doctor.


Since smoking may decrease the treatment effects of this medicine, it is best to avoid smoking while you are using it. If you have any questions about this, check with your doctor.


It is important that your doctor check your skin for melanoma regularly if you have Parkinson's disease. .


Some people who have used this medicine had unusual changes in their behavior. Talk with your doctor if you start having problems with gambling or increased sex drive while using this medicine.


Requip Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor immediately if any of the following side effects occur:


More common
  • Confusion

  • dizziness, faintness, or lightheadedness when getting up from a lying or sitting position suddenly

  • drowsiness

  • falling

  • nausea

  • seeing, hearing, or feeling things that are not there (hallucinations)

  • sleepiness or unusual drowsiness

  • swelling of legs

  • twisting, twitching, or other unusual body movements

  • unusual tiredness or weakness

  • worsening of parkinsonism

Less common
  • Abdominal pain

  • bloating or swelling of the face, arms, hands, lower legs, or feet

  • blood in urine

  • blurred vision

  • burning, pain, or difficulty in urinating

  • chest pain

  • chills

  • cold sweats

  • cough

  • double vision or other eye or vision problems

  • fainting

  • fear or nervousness

  • feeling of constant movement of self or surroundings

  • high or low blood pressure

  • irregular or pounding heartbeat

  • loss of memory

  • mental depression

  • pain

  • pain in arms or legs

  • pounding in the ears

  • rapid weight gain

  • sensation of spinning

  • shortness of breath

  • slow or fast heartbeat

  • sore throat

  • sweating

  • tightness in chest

  • tingling of hands or feet

  • tingling, numbness, or prickly feelings

  • trouble in concentrating

  • troubled breathing

  • unusual weight gain or loss

  • vomiting

  • wheezing

Rare
  • Anxiety

  • buzzing or ringing in the ears

  • changes in vision

  • fever

  • headache

  • joint pain

  • loss of bladder control

  • muscle cramps, pain, or spasms

  • nasal congestion

  • runny nose

  • sneezing

  • trouble in swallowing

  • unusual urges

Get emergency help immediately if any of the following symptoms of overdose occur:


Symptoms of overdose
  • Agitation

  • fatigue

  • grogginess

  • increase in unusual body movements, especially of the face or mouth

  • increased coughing

  • increased sweating

  • lack or loss of strength

  • nightmares

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


Less common
  • Abnormal dreams

  • acid or sour stomach

  • back pain

  • belching

  • decrease in sexual desire or performance

  • difficulty having a bowel movement (stool)

  • dryness of mouth

  • flushing

  • general feeling of discomfort or illness

  • heartburn or gas

  • hot flashes

  • indigestion

  • loss of appetite

  • tremor

  • weight loss

  • yawning

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Requip side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Requip resources


  • Requip Side Effects (in more detail)
  • Requip Use in Pregnancy & Breastfeeding
  • Drug Images
  • Requip Drug Interactions
  • Requip Support Group
  • 29 Reviews for Requip - Add your own review/rating


  • Requip Monograph (AHFS DI)

  • Requip Consumer Overview

  • Requip MedFacts Consumer Leaflet (Wolters Kluwer)

  • Requip Prescribing Information (FDA)

  • Requip XL Extended-Release Tablets MedFacts Consumer Leaflet (Wolters Kluwer)

  • Ropinirole Prescribing Information (FDA)



Compare Requip with other medications


  • Parkinson's Disease
  • Periodic Limb Movement Disorder
  • Restless Legs Syndrome

Wednesday, May 27, 2009

Petinutin




Petinutin may be available in the countries listed below.


Ingredient matches for Petinutin



Mesuximide

Mesuximide is reported as an ingredient of Petinutin in the following countries:


  • Germany

  • Switzerland

International Drug Name Search

Friday, May 22, 2009

Valdol




Valdol may be available in the countries listed below.


Ingredient matches for Valdol



Valdecoxib

Valdecoxib is reported as an ingredient of Valdol in the following countries:


  • Bangladesh

International Drug Name Search

Sunday, May 10, 2009

Exidine




In the US, Exidine is a member of the following drug classes: antiseptic and germicides, mouth and throat products.

Ingredient matches for Exidine



Chlorhexidine

Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Exidine in the following countries:


  • United States

International Drug Name Search

Friday, May 8, 2009

Papaverine HCl PCH




Papaverine HCl PCH may be available in the countries listed below.


Ingredient matches for Papaverine HCl PCH



Papaverine

Papaverine hydrochloride (a derivative of Papaverine) is reported as an ingredient of Papaverine HCl PCH in the following countries:


  • Netherlands

International Drug Name Search

Thursday, April 30, 2009

Bevacizumab Solution


Pronunciation: BE-va-SIZ-ue-mab
Generic Name: Bevacizumab
Brand Name: Avastin

Serious stomach or bowel problems (eg, abscess, fistula, perforation) may occur with Bevacizumab Solution. These effects are not common, but may be serious and sometimes fatal. Tell your doctor right away if you develop unusual stomach pain along with constipation, fever, nausea, or vomiting.


The incidence of wound healing problems and surgical complications, including serious and sometimes fatal complications, is greater in patients who use Bevacizumab Solution. Tell your doctor immediately if you notice any wounds that do not heal or if you have a surgical wound that opens up. Tell your doctor if you are scheduled to have surgery or if you have had surgery within the past 28 days. If possible, you should not use Bevacizumab Solution within 28 days before or after surgery and until the surgical wound is healed. Talk with your doctor for more information.


The risk of severe and sometimes fatal bleeding problems is increased with Bevacizumab Solution. Patients who have severe bleeding or a recent history of coughing up blood should not use Bevacizumab Solution. Contact your doctor right away if you experience unusual bruising or bleeding, including severe or persistent nosebleed; coughing up blood; black, tarry stools; blood in the vomit or vomit that looks like coffee grounds; unusual or severe vaginal bleeding; or stroke symptoms (eg, confusion, slurred speech, vision problems, one-sided weakness).





Bevacizumab Solution is used for:

Treating certain types of advanced lung cancer. It is also used to treat certain types of brain, kidney, colon, or rectal cancer. It is used with other cancer medicines. It may also be used for other conditions as determined by your doctor.


Bevacizumab Solution is a monoclonal antibody. It works by decreasing the formation and growth of new blood vessels in the tumor by blocking the action of a protein called vascular endothelial growth factor (VEGF). This helps to slow the growth and spread of cancer.


Do NOT use Bevacizumab Solution if:


  • you are allergic to any ingredient in Bevacizumab Solution

  • you have a tear or hole (perforation) in your stomach or bowels

  • you have a wound (including a surgical wound) that has not healed or has split apart

  • you have had surgery within the last 28 days

  • you have severe bleeding or have recently coughed up blood

  • you are taking sunitinib

Contact your doctor or health care provider right away if any of these apply to you.



Before using Bevacizumab Solution:


Some medical conditions may interact with Bevacizumab Solution. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are able to become pregnant

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances, including mouse or murine proteins

  • if you have a history of chest pain (eg, angina), high blood pressure, heart problems (eg, congestive heart failure, heart disease, heart attack), blood vessel problems (eg, stroke), bleeding problems, blood clots, or coughing up blood

  • if you have a history of nervous system problems, stomach or bowel problems, kidney problems, or high amounts of protein in your urine

  • if you have a low blood sodium level, a wound that has not fully healed, or if you are scheduled to have surgery

Some MEDICINES MAY INTERACT with Bevacizumab Solution. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Sunitinib because a certain type of severe anemia (eg, hemolytic anemia) may occur

  • Anticoagulants (eg, warfarin) because the risk of bleeding may be increased

This may not be a complete list of all interactions that may occur. Ask your health care provider if Bevacizumab Solution may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Bevacizumab Solution:


Use Bevacizumab Solution as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Bevacizumab Solution is usually given as an injection at your doctor's office, hospital, or clinic. If you will be using Bevacizumab Solution at home, a health care provider will teach you how to use it. Be sure you understand how to use Bevacizumab Solution. Follow the procedures you are taught when you use a dose. Contact your health care provider if you have any questions.

  • Do not use Bevacizumab Solution if it contains particles, is cloudy or discolored, or if the vial is cracked or damaged.

  • Do not shake Bevacizumab Solution.

  • Keep this product, as well as syringes and needles, out of the reach of children and pets. Do not reuse needles, syringes, or other materials. Ask your health care provider how to dispose of these materials after use. Follow all local rules for disposal.

  • If you miss a dose of Bevacizumab Solution, contact your doctor immediately to establish a new dosing schedule.

Ask your health care provider any questions you may have about how to use Bevacizumab Solution.



Important safety information:


  • Bevacizumab Solution may cause dizziness. This effect may be worse if you take it with alcohol or certain medicines. Use Bevacizumab Solution with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • If nausea, vomiting, or loss of appetite occurs, ask your doctor or pharmacist for ways to lessen these effects.

  • Bevacizumab Solution may lower the ability of your body to fight infection. Avoid contact with people who have colds or infections. Tell your doctor if you notice signs of infection like fever, sore throat, rash, or chills.

  • Bevacizumab Solution may reduce the number of clot-forming cells (platelets) in your blood. Avoid activities that may cause bruising or injury. Tell your doctor if you have unusual bruising or bleeding. Tell your doctor if you have dark, tarry, or bloody stools.

  • Bevacizumab Solution may increase the risk of blood clots in your arteries or veins. This can lead to serious effects such as stroke, heart attack, or a blood clot in the lung (pulmonary embolism). Tell your doctor right away if you develop symptoms of a blood clot (eg, pain, redness, swelling, or tenderness in an arm or leg; shortness of breath; coughing up blood), symptoms of stroke (eg, confusion, slurred speech, vision problems, one-sided weakness), or symptoms of a heart attack (eg, chest pain; numbness of an arm or leg; fainting; sudden, severe headache or vomiting).

  • Bevacizumab Solution may cause a serious brain problem called reversible posterior leukoencephalopathy syndrome (RPLS). If RPLS occurs, symptoms may appear from 16 hours to 1 year after starting Bevacizumab Solution. Contact your doctor right away if you experience severe headache, seizures, sluggishness, confusion, vision changes, or loss of vision.

  • Bevacizumab Solution may cause infertility in women. If you are able to become pregnant, discuss any questions or concerns that you have about this information with your doctor.

  • Talk with your doctor before you receive any vaccine while you are using Bevacizumab Solution.

  • Tell your doctor or dentist that you take Bevacizumab Solution before you receive any medical or dental care, emergency care, or surgery.

  • Lab tests, including blood pressure, complete blood cell counts, and urine protein levels, may be performed while you use Bevacizumab Solution. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.

  • Use Bevacizumab Solution with caution in the ELDERLY; they may be more sensitive to its effects, especially the risk of blood clotting problems (eg, heart attack, stroke).

  • Bevacizumab Solution should be used with extreme caution in CHILDREN; safety and effectiveness in children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: Bevacizumab Solution may cause harm to the fetus. Do not become pregnant while you are using it. If you think you may be pregnant, contact your doctor. You will need to discuss the benefits and risks of using Bevacizumab Solution while you are pregnant. If you are able to become pregnant, talk with your doctor or pharmacist about the use of effective birth control while taking Bevacizumab Solution and for at least 6 months following the last dose of Bevacizumab Solution. It is not known if Bevacizumab Solution is found in breast milk. Do not breast-feed while taking Bevacizumab Solution. Do not become pregnant or breast-feed immediately after you stop Bevacizumab Solution. Bevacizumab Solution can stay in your body for a long time after you stop using it. Talk with your doctor about when it may be safe to become pregnant or breast-feed.


Possible side effects of Bevacizumab Solution:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Back pain; changes in taste; constipation; diarrhea; dizziness; dry mouth; dry skin; headache; increased thirst; indigestion; loss of appetite; minor nosebleeds; mouth or tongue pain, swelling, or sores; muscle pain; nausea; pain, swelling, or redness at the injection site; stuffy or runny nose; tiredness; voice changes; vomiting; weakness.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); black, tarry stools; blood in the urine; burning, numbness, or tingling; chest pain; coughing up blood; decreased urination; fainting; fever, chills, or persistent sore throat; red, swollen, blistered, or peeling skin; seizure; severe or persistent headache or dizziness; severe or persistent nosebleed; severe or persistent stomach pain, constipation, nausea, or vomiting; severe or persistent weakness; shortness of breath; swelling of the hands, ankles, or feet; swelling or pain in the jaw; unusual bruising or bleeding; unusual or severe sweating; unusual weight gain or loss; vision loss, blurred vision, or other vision changes; vomit that looks like coffee grounds; wheezing; wounds that do not heal.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Bevacizumab side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include severe headache.


Proper storage of Bevacizumab Solution:

Bevacizumab Solution is usually handled and stored by a health care provider. If you are using Bevacizumab Solution at home, store Bevacizumab Solution as directed by your pharmacist or health care provider. Keep Bevacizumab Solution out of the reach of children and away from pets.


General information:


  • If you have any questions about Bevacizumab Solution, please talk with your doctor, pharmacist, or other health care provider.

  • Bevacizumab Solution is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Bevacizumab Solution. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Bevacizumab resources


  • Bevacizumab Side Effects (in more detail)
  • Bevacizumab Use in Pregnancy & Breastfeeding
  • Bevacizumab Drug Interactions
  • Bevacizumab Support Group
  • 6 Reviews for Bevacizumab - Add your own review/rating


Compare Bevacizumab with other medications


  • Breast Cancer
  • Breast Cancer, Metastatic
  • Colorectal Cancer
  • Glioblastoma Multiforme
  • Macular Degeneration
  • Malignant Glioma
  • Neurofibromatosis
  • Non-Small Cell Lung Cancer
  • Ovarian Cancer
  • Pancreatic Cancer
  • Renal Cell Carcinoma
  • Solid Tumors

Friday, April 24, 2009

Biopatch




In the US, Biopatch (chlorhexidine topical) is a member of the following drug classes: antiseptic and germicides, mouth and throat products and is used to treat Gingivitis, Mucositis and Periodontitis.

US matches:

  • Biopatch

  • Biopatch w/Chlorhexidine Gluconate

Ingredient matches for Biopatch



Chlorhexidine

Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Biopatch in the following countries:


  • United States

International Drug Name Search

Tuesday, April 21, 2009

Apo-Triazide




Apo-Triazide may be available in the countries listed below.


Ingredient matches for Apo-Triazide



Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Apo-Triazide in the following countries:


  • Canada

  • Singapore

Triamterene

Triamterene is reported as an ingredient of Apo-Triazide in the following countries:


  • Canada

  • Singapore

International Drug Name Search

Tuesday, March 31, 2009

Saquinavir Mesylate




Saquinavir Mesylate may be available in the countries listed below.


Ingredient matches for Saquinavir Mesylate



Saquinavir

Saquinavir Mesylate (BANM, USAN) is known as Saquinavir in the US.

International Drug Name Search

Glossary

BANMBritish Approved Name (Modified)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Monday, March 23, 2009

Biaminthic




Biaminthic may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Biaminthic



Levamisole

Levamisole hydrochloride (a derivative of Levamisole) is reported as an ingredient of Biaminthic in the following countries:


  • France

International Drug Name Search

Monday, March 16, 2009

Bromfed DM


Generic Name: brompheniramine, dextromethorphan, and pseudoephedrine (brom fen EER a meen, dex troe me THOR fan, soo doe e FED rin)

Brand Names: Allanhist PDX Drops, Anaplex DM, Anaplex DMX, Andehist DM NR Syrup, Brom Tann, Bromaline DM, Bromdex D, Bromfed DM, Bromhist PDX, Bromhist-DM Drops, Bromophed-DX, Bromph DM, Bromplex DM, BroveX PSE DM, Dallergy DM, EndaCof-DM, Histacol BD Drops, Myphetane DX Cough, Neo DM, PBM Allergy, Pediahist DM Drops, ProHist DM, Q-Tapp DM, Resperal-DM Drops, Robitussin Allergy & Cough, Sildec DM


What is Bromfed DM (brompheniramine, dextromethorphan, and pseudoephedrine)?

Brompheniramine is an antihistamine that reduces the effects of the natural chemical histamine in the body. Histamine can produce symptoms of sneezing, itching, watery eyes, and runny nose.


Dextromethorphan is a cough suppressant. It affects the signals in the brain that trigger cough reflex.


Pseudoephedrine is a decongestant that shrinks blood vessels in the nasal passages. Dilated blood vessels can cause nasal congestion (stuffy nose).


The combination of brompheniramine, dextromethorphan, and pseudoephedrine is used to treat runny or stuffy nose, sneezing, itching, watery eyes, cough, and sinus congestion caused by allergies, the common cold, or the flu.


This medicine will not treat a cough that is caused by smoking, asthma, or emphysema.

Brompheniramine, dextromethorphan, and pseudoephedrine may also be used for purposes not listed in this medication guide.


What is the most important information I should know about Bromfed DM (brompheniramine, dextromethorphan, and pseudoephedrine)?


Dosage - adults and children 12 years and over: 2 teaspoonfuls every 4 hours. Children 6 to under 12 years: 1 teaspoonful every 4 hours. Children 2 to under 6 years of age: half a teaspoonful every 4 hours. Infants 6 months to under 2 years of age: dosage to be established by a physician. Always ask a doctor before giving a cough or cold medicine to a child. Death can occur from the misuse of cough and cold medicines in very young children. You should not use this medication if you have severe constipation, a blockage in your stomach or intestines, or if you are unable to urinate. Do not use cough or cold medicine if you have untreated or uncontrolled diseases such as glaucoma, asthma or COPD, high blood pressure, heart disease, coronary artery disease, or overactive thyroid. Do not use cough or cold medicine if you have used an MAO inhibitor such as furazolidone (Furoxone), isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam, Zelapar), or tranylcypromine (Parnate) in the last 14 days. A dangerous drug interaction could occur, leading to serious side effects.

What should I discuss with my healthcare provider before taking Bromfed DM (brompheniramine, dextromethorphan, and pseudoephedrine)?


Do not use cough or cold medicine if you have used an MAO inhibitor such as furazolidone (Furoxone), isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam, Zelapar), or tranylcypromine (Parnate) in the last 14 days. A dangerous drug interaction could occur, leading to serious side effects. You should not use this medication if you have severe constipation, a blockage in your stomach or intestines, or if you are unable to urinate. Do not use cough or cold medicine if you have untreated or uncontrolled diseases such as glaucoma, asthma or COPD, high blood pressure, heart disease, coronary artery disease, or overactive thyroid.

Ask a doctor or pharmacist if it is safe for you to take this medication if you have:



  • a blockage in your digestive tract (stomach or intestines), a colostomy or ileostomy;




  • diabetes;




  • liver or kidney disease;




  • epilepsy or other seizure disorder;




  • cough with mucus, or cough caused by emphysema or chronic bronchitis;




  • enlarged prostate or urination problems;




  • low blood pressure;




  • pheochromocytoma (an adrenal gland tumor); or




  • if you take potassium (Cytra, Epiklor, K-Lyte, K-Phos, Kaon, Klor-Con, Polycitra, Urocit-K).




FDA pregnancy category C. It is not known whether this medication will harm an unborn baby. Do not use cough or cold medicine without medical advice if you are pregnant. This medicine may pass into breast milk and may harm a nursing baby. Antihistamines and decongestants may also slow breast milk production. Do not use cough or cold medicine without medical advice if you are breast-feeding a baby.

How should I take Bromfed DM (brompheniramine, dextromethorphan, and pseudoephedrine)?


Use exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended. Cough or cold medicine is usually taken only for a short time until your symptoms clear up.


Dosage - adults and children 12 years and over: 2 teaspoonfuls every 4 hours. Children 6 to under 12 years: 1 teaspoonful every 4 hours. Children 2 to under 6 years of age: half a teaspoonful every 4 hours. Infants 6 months to under 2 years of age: dosage to be established by a physician. Always ask a doctor before giving a cough or cold medicine to a child. Death can occur from the misuse of cough and cold medicines in very young children.

Do not take for longer than 7 days in a row. Talk with your doctor if your symptoms do not improve after 7 days of treatment, or if you have a fever with a headache or skin rash.


Measure liquid medicine with a special dose-measuring spoon or medicine cup, not with a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist for one.


If you need surgery or medical tests, tell the surgeon or doctor ahead of time if you have taken a cough or cold medicine within the past few days. Store at room temperature away from moisture and heat. Do not freeze.

What happens if I miss a dose?


Since cough or cold medicine is taken when needed, you may not be on a dosing schedule. If you are taking the medication regularly, take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

Overdose symptoms may include severe forms of some of the side effects listed in this medication guide.


What should I avoid while taking Bromfed DM (brompheniramine, dextromethorphan, and pseudoephedrine)?


This medicine may cause blurred vision and may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be alert and able to see clearly. Drinking alcohol can increase certain side effects of this medication. Ask a doctor or pharmacist before using any other cold, allergy, cough, or sleep medicine. Antihistamines, cough suppressants, and decongestants are contained in many combination medicines. Taking certain products together can cause you to get too much of a certain drug. Check the label to see if a medicine contains an antihistamine, cough suppressant, or decongestant.

Avoid taking this medication if you also take diet pills, caffeine pills, or other stimulants (such as ADHD medications). Taking a stimulant together with a decongestant can increase your risk of unpleasant side effects.


Avoid becoming overheated or dehydrated during exercise and in hot weather. This medication can decrease sweating and you may be more prone to heat stroke.

Bromfed DM (brompheniramine, dextromethorphan, and pseudoephedrine) side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat. Stop using this medicine and call your doctor at once if you have a serious side effect such as:

  • fast, slow, or uneven heart rate;




  • severe headache, mood changes, hallucinations;




  • severe dizziness or anxiety, feeling like you might pass out;




  • tremor, seizure (convulsions);




  • easy bruising or bleeding, unusual weakness;




  • fever;




  • urinating less than usual or not at all;




  • feeling short of breath; or




  • dangerously high blood pressure (severe headache, blurred vision, buzzing in your ears, anxiety, confusion, chest pain, uneven heartbeats, seizure).



Less serious side effects may include:



  • mild headache;




  • mild dizziness, drowsiness;




  • dry mouth, nose, or throat;




  • nausea, diarrhea, constipation, upset stomach;




  • feeling nervous, restless, or irritable;




  • blurred vision; or




  • sleep problems (insomnia).



This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect Bromfed DM (brompheniramine, dextromethorphan, and pseudoephedrine)?


Ask a doctor or pharmacist before using this medicine if you regularly use other medicines that make you sleepy (such as narcotic pain medication, sedatives, sleeping pills, muscle relaxers, and medicine for seizures, depression or anxiety). They can add to sleepiness caused by brompheniramine or dextromethorphan.


Ask a doctor or pharmacist if it is safe for you to take this medication if you are also using any of the following drugs:



  • atropine (Atreza, Sal-Tropine);




  • benztropine (Cogentin);




  • topiramate (Topamax);




  • zonisamide (Zonegran);




  • an antidepressant such as citalopram (Celexa), duloxetine (Cymbalta), escitalopram (Lexapro), fluoxetine (Prozac, Sarafem, Symbyax), paroxetine (Paxil, Pexeva), sertraline (Zoloft), venlafaxine (Effexor), and others;




  • anti-nausea medications such as belladonna (Donnatal), dimenhydrinate (Dramamine), droperidol (Inapsine), methscopolamine (Pamine), or scopolamine (Transderm Scop);




  • bladder or urinary medications such as darifenacin (Enablex), flavoxate (Urispas), oxybutynin (Ditropan, Oxytrol), solifenacin (Vesicare), tolterodine (Detrol), or Urogesic Blue;




  • bronchodilators such as ipratropium (Atrovent) or tiotropium (Spiriva);




  • irritable bowel medications such as dicyclomine (Bentyl), hyoscyamine (Hyomax), or propantheline (Pro Banthine); or




  • ulcer medicine such as glycopyrrolate (Robinul) or mepenzolate (Cantil).



This list is not complete and other drugs may interact with brompheniramine, dextromethorphan, and pseudoephedrine. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.



More Bromfed DM resources


  • Bromfed DM Side Effects (in more detail)
  • Bromfed DM Use in Pregnancy & Breastfeeding
  • Bromfed DM Drug Interactions
  • Bromfed DM Support Group
  • 0 Reviews for Bromfed DM - Add your own review/rating


  • Bromfed DM Prescribing Information (FDA)

  • Bromfed DM Elixir MedFacts Consumer Leaflet (Wolters Kluwer)

  • Anaplex DMX Suspension MedFacts Consumer Leaflet (Wolters Kluwer)

  • Bromdex D Prescribing Information (FDA)

  • Myphetane DX Prescribing Information (FDA)

  • Neo DM Suspension MedFacts Consumer Leaflet (Wolters Kluwer)

  • Resperal-DM Drops MedFacts Consumer Leaflet (Wolters Kluwer)



Compare Bromfed DM with other medications


  • Cough and Nasal Congestion


Where can I get more information?


  • Your pharmacist can provide more information about brompheniramine, dextromethorphan, and pseudoephedrine.

See also: Bromfed DM side effects (in more detail)


Friday, March 13, 2009

Eubrain




Eubrain may be available in the countries listed below.


Ingredient matches for Eubrain



Piracetam

Piracetam is reported as an ingredient of Eubrain in the following countries:


  • Taiwan

International Drug Name Search

Wednesday, March 11, 2009

Loperamid AL




Loperamid AL may be available in the countries listed below.


Ingredient matches for Loperamid AL



Loperamide

Loperamide hydrochloride (a derivative of Loperamide) is reported as an ingredient of Loperamid AL in the following countries:


  • Germany

International Drug Name Search

Monday, March 9, 2009

Revlimid



Pronunciation: LEN-a-LID-oh-mide
Generic Name: Lenalidomide
Brand Name: Revlimid

Revlimid may cause severe birth defects or death of the fetus if used during pregnancy. Revlimid is similar to thalidomide, which causes life-threatening birth defects.


Females who are able to become pregnant and who take Revlimid:


  • must not become pregnant;

  • must avoid sexual contact with men or use at least 2 forms of effective birth control for 4 weeks before starting Revlimid, while taking Revlimid, during dose interruptions, and for 4 weeks after stopping Revlimid;

  • must have a negative pregnancy test 10 to 14 days before starting Revlimid and again within 24 hours before starting Revlimid; and

  • must have a pregnancy test every week for the first 4 weeks after starting Revlimid and then every 2 to 4 weeks thereafter while using Revlimid.

Women who experience abnormal menstrual bleeding, miss their menstrual period, become pregnant, or suspect for any reason they may be pregnant while taking Revlimid must stop taking it and contact their doctor immediately.


Males who take Revlimid must either:


  • avoid sexual contact with women who are pregnant or could become pregnant while taking Revlimid and for 4 weeks after stopping Revlimid; OR

  • use a latex condom during sexual contact with women who are pregnant or could become pregnant for as long as they are taking Revlimid and for 4 weeks after stopping Revlimid, even if they have had a successful vasectomy.

Men who have unprotected sexual contact with a woman who is pregnant or may become pregnant or who think for any reason that their sexual partner may be pregnant should contact their doctor immediately.


All patients who take Revlimid:


  • It is not known if Revlimid passes into semen. Female partners of men taking Revlimid should call their doctor if they become pregnant.

  • All patients must receive and understand all oral and written warnings about the risks of using Revlimid.

  • All patients must be able to follow the instructions for using Revlimid and for using effective birth control methods if they are sexually active.

  • Revlimid may cause an increased risk of blood clots in the veins and lungs. Call your doctor right away if you experience shortness of breath; chest pain; or pain, redness, tenderness, or swelling in the arms or legs.

  • Revlimid often lowers the number of white blood cells and platelets in the blood. Call your doctor right away if you experience unusual bleeding or bruising, fever, chills, or sore throat.

  • Blood counts should be checked each week for the first 8 weeks after starting Revlimid and at least once per month thereafter. If low blood counts develop, it may be necessary to lower the dose or stop treatment. Sometimes blood transfusions and treatment with other medicines may be necessary. Keep all doctor and lab appointments while using Revlimid.




Revlimid is used for:

Treating anemia in patients who have certain types of myelodysplastic syndrome (MDS). It is also used along with dexamethasone to treat a certain type of cancer (multiple myeloma) in certain patients.


Revlimid is an immunomodulatory medicine. Exactly how it works is not known.


Do NOT use Revlimid if:


  • you are allergic to any ingredient in Revlimid

  • you are pregnant, planning to become pregnant, could become pregnant, or become pregnant during treatment with Revlimid

  • you have had a severe allergic reaction (eg, rash; hives; hoarseness; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue) or a severe rash (eg, red, swollen, blistered, or peeling skin) from Revlimid or thalidomide in the past

Contact your doctor or health care provider right away if any of these apply to you.



Before using Revlimid:


Some medical conditions may interact with Revlimid. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have a tumor, cancer, kidney problems, certain hereditary problems (glucose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption), low white blood cell levels, or low platelet counts or if you receive dialysis

  • if you have an infection, blood electrolyte problems, high blood pressure, or a history of blood clots or heart problems (eg, irregular heartbeat, heart attack)

Some MEDICINES MAY INTERACT with Revlimid. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Erythropoietic agents (eg, erythropoietin), estrogens (eg, estrogen, estradiol), progestins (eg, medroxyprogesterone), or medicines that contain estrogens or progestins (eg, birth control pills) because the risk of developing blood clots may be increased

  • Digoxin because the risk of its side effects may be increased by Revlimid

This may not be a complete list of all interactions that may occur. Ask your health care provider if Revlimid may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Revlimid:


Use Revlimid as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Revlimid comes with an extra patient information sheet called a Medication Guide. Read it carefully. Read it again each time you get Revlimid refilled.

  • Revlimid can only be prescribed and dispensed through a special program. Make sure you understand all warnings and instructions for using Revlimid. Ask your doctor or pharmacist if you have any questions about this program or the use of Revlimid.

  • Take Revlimid by mouth with or without food.

  • Swallow Revlimid whole with water. Do not break, crush, or chew before swallowing.

  • Women who are able to become pregnant (including those who have started menopause within the last 24 months) must use at least 2 methods of effective birth control while taking Revlimid, unless they are not sexually active. These birth control methods must be used for at least 4 weeks before starting Revlimid, while taking Revlimid, during dose interruptions, and for 4 weeks after stopping Revlimid. Talk with your doctor about which methods of effective birth control may be appropriate for you.

  • Men who take Revlimid must always use a latex condom during any sexual contact with a woman who is pregnant or could become pregnant. Do this for as long as you are taking Revlimid and for 4 weeks after you stop taking it. This includes men who have had a vasectomy.

  • Do not open the capsules or handle them more than needed. If you touch a broken capsule or the medicine inside of the capsule, wash the area with soap and water.

  • If you miss a dose of Revlimid and it has been less than 12 hours since the missed dose, take it as soon as you remember. If it has been more than 12 hours since the missed dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Revlimid.



Important safety information:


  • Revlimid may cause dizziness. This effect may be worse if you take it with alcohol or certain medicines. Use Revlimid with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Revlimid may reduce the number of clot-forming cells (platelets) in your blood. Avoid activities that may cause bruising or injury. Tell your doctor if you have unusual bruising or bleeding. Tell your doctor if you have dark, tarry, or bloody stools.

  • Revlimid may lower the ability of your body to fight infection. Avoid contact with people who have colds or infections. Tell your doctor if you notice signs of infection like fever, sore throat, rash, or chills.

  • Revlimid may increase the risk of blood clots in certain patients. Tell your doctor at once if you notice shortness of breath; chest pain; or pain, redness, tenderness, or swelling of an arm or leg.

  • Patients with cancer who take Revlimid have a risk of developing a serious and possibly fatal condition called tumor lysis syndrome (TLS). Contact your doctor right away if you develop symptoms such as fast or irregular heartbeat; fainting; decreased urination; muscle weakness or cramps; nausea, vomiting, diarrhea, or loss of appetite; or sluggishness.

  • Do not donate semen, sperm, or blood while taking Revlimid or within 4 weeks after stopping Revlimid.

  • If you are using a hormonal contraceptive (eg, birth control pills) to prevent pregnancy, inform your doctor if you also take an HIV protease inhibitor (eg, ritonavir); griseofulvin, rifampin, rifabutin, penicillin, amoxicillin, ampicillin, or other antibiotic medicines; St. John's wort; modafinil; phenytoin; or carbamazepine. These medicines may decrease the effectiveness of hormonal contraceptives.

  • Lab tests, including pregnancy tests and complete blood cell counts, may be performed while you use Revlimid. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.

  • Use Revlimid with caution in the ELDERLY; they may be more sensitive to its effects.

  • Revlimid should be used with extreme caution in CHILDREN younger than 18 years old; safety and effectiveness in these children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: Use of Revlimid during pregnancy may cause severe birth defects and death of the fetus. If you think you may be pregnant, miss your menstrual period, experience unusual menstrual bleeding, or stop using birth control, contact your doctor right away. If you become pregnant while using Revlimid, consult an obstetrician/gynecologist experienced in reproductive toxicity. It is not known if Revlimid is found in breast milk. Do not breast-feed while taking Revlimid.


Possible side effects of Revlimid:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Back pain; constipation; cough; diarrhea; dizziness; dry mouth or skin; headache; increased sweating or night sweats; loss of appetite; mild stomach pain; nausea; sluggishness; stuffy or runny nose; taste changes; tiredness; trouble sleeping; vomiting; weakness.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; hoarseness; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); blood in the stools or vomit; burning, numbness, or tingling; chest pain; confusion; dark urine; depression; difficulty swallowing; fainting; fast, slow, or irregular heartbeat; fever, chills, or sore throat; joint pain; muscle pain, weakness, or cramps; one-sided weakness; pain, numbness, tingling, tenderness, redness, or swelling of the arms or legs; painful or difficult urination; red, swollen, blistered, or peeling skin; reduces senses of touch; severe or persistent headache, dizziness, or stomach pain; severe tiredness or weakness; shortness of breath; slurred speech; swelling of the hands, ankles, or feet; tremor; unusual bruising or bleeding; vision problems.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Revlimid side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.


Proper storage of Revlimid:

Store Revlimid at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Revlimid out of the reach of children and away from pets.


General information:


  • If you have any questions about Revlimid, please talk with your doctor, pharmacist, or other health care provider.

  • Revlimid is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Revlimid. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Revlimid resources


  • Revlimid Side Effects (in more detail)
  • Revlimid Use in Pregnancy & Breastfeeding
  • Revlimid Drug Interactions
  • Revlimid Support Group
  • 1 Review for Revlimid - Add your own review/rating


  • Revlimid Prescribing Information (FDA)

  • Revlimid Consumer Overview

  • Revlimid Monograph (AHFS DI)

  • Revlimid Advanced Consumer (Micromedex) - Includes Dosage Information

  • Lenalidomide Professional Patient Advice (Wolters Kluwer)



Compare Revlimid with other medications


  • Anemia
  • Multiple Myeloma